Myocardial infarction type 4b in human immunodeficiency virus-infected patient.
We report a case of a 52-year-old human immunodeficiency virus (HIV)-infected male patient receiving combined antiretroviral therapy (cART), who presented with acute ST-elevation myocardial infarction (STEMI). He was properly treated (e.g., prescribed anti-coagulation drugs: aspirin, clopidogrel, enoxaparin) and discharged. After 1.5 months, another STEMI related with in-stent thrombosis took place. The cART scheme was altered, resulting in no further cardiac events in the follow-up period, with undetectable levels of HIV ribonucleic acid. This case highlights the association between HIV infection and the specific drugs of cART, and the risk of cardiovascular disease development.
Department of Hepatology and Acquired Immunodeficiencies, Medical University of Warsaw, Warsaw, Poland.
Aneta
A
Cybula-Walczak
Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Filip M
FM
Szymanski
Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Anna E
AE
Platek
Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
Grzegorz
G
Karpinski
Antiretroviral therapy; Human immunodeficiency virus; Myocardial infarction